142 related articles for article (PubMed ID: 29641561)
1. Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.
Figueroa DB; Tillotson J; Li M; Piwowar-Manning E; Hendrix CW; Holtz TH; Bokoch K; Bekker LG; van Griensven F; Mannheimer S; Hughes JP; Grant RM; Bumpus NN
PLoS One; 2018; 13(4):e0195764. PubMed ID: 29641561
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner.
Lade JM; To EE; Hendrix CW; Bumpus NN
EBioMedicine; 2015 Sep; 2(9):1145-52. PubMed ID: 26501112
[TBL] [Abstract][Full Text] [Related]
3. Naturally Occurring Mutations to Muscle-Type Creatine Kinase Impact Its Canonical and Pharmacological Activities in a Substrate-Dependent Manner In Vitro.
Mosher EP; Eberhard CD; Bumpus NN
Mol Pharmacol; 2021 Dec; 100(6):588-596. PubMed ID: 34561299
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.
Figueroa DB; Madeen EP; Tillotson J; Richardson P; Cottle L; McCauley M; Landovitz RJ; Andrade A; Hendrix CW; Mayer KH; Wilkin T; Gulick RM; Bumpus NN
AIDS Res Hum Retroviruses; 2018 May; 34(5):421-429. PubMed ID: 29455571
[TBL] [Abstract][Full Text] [Related]
5. High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarate.
Margot NA; Liu Y; Miller MD; Callebaut C
Antiviral Res; 2016 Aug; 132():50-8. PubMed ID: 27208653
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
7. Expression, Activity, and Regulation of Phosphorylating Enzymes in Tissues and Cells Relevant to HIV-1 Sexual Transmission.
Hu M; Valicherla GR; Zhou T; Hillier SL; Rohan LC
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):22-32. PubMed ID: 33567990
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa.
Skhosana L; Steegen K; Bronze M; Lukhwareni A; Letsoalo E; Papathanasopoulos MA; Carmona SC; Stevens WS
PLoS One; 2015; 10(2):e0118145. PubMed ID: 25659108
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures.
Stray KM; Park Y; Babusis D; Callebaut C; Cihlar T; Ray AS; Perron M
Antiviral Res; 2017 Apr; 140():116-120. PubMed ID: 28131805
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients.
Valade E; Bouazza N; Lui G; Illamola SM; Benaboud S; Treluyer JM; Cobat A; Foissac F; De Sousa Mendes M; Chenevier-Gobeaux C; Suzan-Monti M; Rouzioux C; Assoumou L; Viard JP; Urien S; Ghosn J; Hirt D
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956420
[TBL] [Abstract][Full Text] [Related]
11. Treatment. Tenofovir-resistant HIV increasing in Africa.
AIDS Policy Law; 2016 Mar; 31(4):1. PubMed ID: 27372984
[No Abstract] [Full Text] [Related]
12. Mutations in muscle-type creatine kinase impact HIV prevention.
Migliorati JM; Zhong XB
Trends Pharmacol Sci; 2022 Mar; 43(3):165-167. PubMed ID: 34887127
[TBL] [Abstract][Full Text] [Related]
13. Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
Casadellà M; Noguera-Julian M; Sunpath H; Gordon M; Rodriguez C; Parera M; Kuritzkes DR; Marconi VC; Paredes R
AIDS; 2016 Apr; 30(7):1137-40. PubMed ID: 26807968
[TBL] [Abstract][Full Text] [Related]
14. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Taneva E; Crooker K; Park SH; Su JT; Ott A; Cheshenko N; Szleifer I; Kiser PF; Frank B; Mesquita PM; Herold BC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1667-75. PubMed ID: 26711762
[TBL] [Abstract][Full Text] [Related]
15. Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.
Ngandu NK; Carlson JM; Chopera DR; Ndabambi N; Abdool Karim Q; Abdool Karim S; Williamson C
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):43-47. PubMed ID: 28797020
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.
Kozal MJ; Chiarella J; St John EP; Moreno EA; Simen BB; Arnold TE; Lataillade M
Antivir Ther; 2011; 16(6):925-9. PubMed ID: 21900725
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of kinases on the activation of tenofovir, an anti-HIV agent.
Varga A; Gráczer E; Chaloin L; Liliom K; Závodszky P; Lionne C; Vas M
Eur J Pharm Sci; 2013 Jan; 48(1-2):307-15. PubMed ID: 23201309
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovir.
Hamlin AN; Tillotson J; Bumpus NN
Pharmacogenomics; 2019 Jan; 20(2):105-111. PubMed ID: 30628547
[TBL] [Abstract][Full Text] [Related]
20. Hypomorphic variants in AK2 reveal the contribution of mitochondrial function to B-cell activation.
Chou J; Alazami AM; Jaber F; Hoyos-Bachiloglu R; Jones J; Weeks S; Alosaimi MF; Bainter W; Cangemi B; Badran YR; Mohammed R; Alroqi F; Almutairi A; Al-Onazi N; AlAjaji S; Al-Saud B; Arnaout R; Elkins M; Devana S; Imperial J; Li B; Drexhage L; Abdel Rahman AM; Jacob M; Haddad H; Hanna-Wakim R; Dbaibo G; Massaad MJ; Dasouki M; Mikhael R; Baz Z; Geha RS; Al-Mousa H
J Allergy Clin Immunol; 2020 Jul; 146(1):192-202. PubMed ID: 31862378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]